Use of corticosteroids in SARS-CoV-2 infection: foe, or can they become a friend? Authors' reply.

Pei, Lei; Zhang, Sheng; Geng, Xuqiang; Li, Wenfang; Chen, Dechang

Pei, Lei; Zhang, Sheng; Geng, Xuqiang; Li, Wenfang; Chen, Dechang.

Afiliação

Pei L; Department of Critical Care Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, China
Zhang S; Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Geng X; Department of Rheumatology and Immunology, Changzheng Hospital, Second Military Medical University, Shanghai, China
Li W; Department of Critical Care Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, China. chzhedlwf@163.com
Chen D; Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Pol Arch Intern Med ; 130(10): 922-923, 2020 10 29.

Article em En | MEDLINE | ID: mdl-33119226

Assuntos

Antivirais; Infecções por Coronavirus; Coronavirus; Pandemias; Pneumonia Viral; Corticosteroides; Antibacterianos; Betacoronavirus; COVID-19; Amigos; Glucocorticoides; Humanos; Imunoglobulinas Intravenosas; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Pneumonia Viral / Infecções por Coronavirus / Coronavirus / Pandemias Limite: Humans Idioma: En Revista: Pol Arch Intern Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google